Valeo Financial Advisors, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Valeo Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$128.63 - $176.89 $5,788 - $7,960	-45 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$126.83 - $175.69 $253 - $351	-2 Reduced 4.26%	45 $6,000
Q3 2020 Oct 28, 2020	SELL	$121.19 - $165.49 $7,998 - $10,922	-66 Reduced 58.41%	47 $7,000
Q1 2020 Apr 13, 2020	BUY	$93.12 - $133.99 $5,959 - $8,575	64 Added 130.61%	113 $13,000
Q2 2019 Jul 10, 2019	SELL	$65.86 - $92.79 $461 - $649	-7 Reduced 12.5%	49 $4,000
Q3 2018 Nov 01, 2018	BUY	$87.52 - $122.67 $437 - $613	5 Added 9.8%	56 $4,000
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $3,699 - $6,031	51	51 $6,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.